Thread: A hint from Oxford Biomedica?
View Single Post
Old 03-14-2009, 03:04 PM
caldeerster caldeerster is offline
Junior Member
  
Join Date: Aug 2007
Posts: 81
15 yr Member
caldeerster caldeerster is offline
Junior Member
 
Join Date: Aug 2007
Posts: 81
15 yr Member
Default A hint from Oxford Biomedica?
Oxford BioMedica looks to move on from a challenging 2008
Friday , March 13, 2009

<excerpt>

It also has promising results from ProSavin, a novel gene-based treatment for Parkinson's disease currently in a phase I/II trial.

Dawson added: "Both TroVax and ProSavin have substantial potential for value creation. By concentrating our resources on these programmes, maintaining our financial flexibility and pursuing our commercial activities, I believe that we are well-positioned for the future."

<excerpt>

http://www.pharmafocus.com/cda/focus...492595,00.html
caldeerster is offline   Reply With QuoteReply With Quote